KIVA’s VCF system successfully treats painful metastases osteolytic vertebra in 40 patients

OSTEOLYTIC VERTEBRA METASTASES TREATED WITH KIVA (Orthopedics This Week) A physician-driven study of 40 patients with painful osteolytic vertebra metastases who investigators treated with the Kiva VCF Treatment System by Benvenue Medical, Inc. found that all of the patients experienced a clinically relevant improvement in their pain and statistically significant functional improvement at the end of one month. According to the researchers, the group experienced a 95% functional improvement and none of the 37 patients who wore a brace prior to intervention required a brace post-procedure. The editors of Pain Physician Journal published the study results in the March/April issue as well as online. Osteolytic vertebra metastases are malignant bone tumors that can cause the spine to collapse resulting in significant pain, disability and even death. Benvenue officials note that many traditional treatments, such as vertebroplasty and kyphoplasty—often performed to alleviate pain—are inappropriate for patients suffering from vertebral metastases because of the risk of serious complications, especially cement extravasation. Giovanni Carlo Anselmetti, M.D., an interventional radiologist in T...


Unlock the full article and exclusive OrthoStreams insights: in-depth analyses, hot startups, trends, market intel, and Daily Newsletter—for just $1/day.
Subscribe Now—Up your Game !
 

Scroll to Top